HomeTRYP • CNSX
add
Tryp Therapeutics Inc
Previous close
$0.060
Year range
$0.010 - $0.11
Market cap
5.73M CAD
Avg Volume
87.26K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Feb 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.24M | 76.79% |
Net income | -2.96M | -130.40% |
Net profit margin | — | — |
Earnings per share | -0.01 | 0.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Feb 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.26M | 2,779.41% |
Total assets | 2.11M | 321.48% |
Total liabilities | 19.69M | 890.79% |
Total equity | -17.58M | — |
Shares outstanding | 289.26M | — |
Price to book | -1.00 | — |
Return on assets | -250.60% | — |
Return on capital | 725.33% | — |
Cash Flow
Net change in cash
(CAD) | Feb 2024info | Y/Y change |
---|---|---|
Net income | -2.96M | -130.40% |
Cash from operations | -6.91M | -775.88% |
Cash from investing | — | — |
Cash from financing | 5.40M | — |
Net change in cash | -1.52M | -92.04% |
Free cash flow | -333.42K | -13.26% |
About
Founded
2019
Headquarters
Website